Cyclotron for Molecular Imaging Program at USC
Cyclotron for Molecular Imaging Program at USC
批准号:
7841076
负责人:
Peter Stephen Conti
金额:
$308.2万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2015-04-30
关键词:
AgeAreaAwardCellsChemistryCitiesClinicalCommunitiesComplementContract ServicesCyclotronsDevicesDiagnosticDisciplineEngineeringFundingFutureHealth SciencesHousingHumanImageInstitutesIsotopesLaboratory AnimalsMagnetic Resonance ImagingMedicalMedicineMonitorNational Center for Research ResourcesNuclearOccupationsOperating SystemOpticsPharmacologyPositronPositron-Emission TomographyProductionProductivityPublic HealthRadiationRadioRadioactivityRadiochemistryRadioisotopesRadiopharmaceuticalsRequest for ProposalsResearchResearch PersonnelSafetySecurityServicesSiteSupport SystemSystemUltrasonographyUnited States National Institutes of HealthWorkinstrumentminiaturizemolecular imagingoperationpre-clinicalprograms
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): During the last several years, a molecular Imaging Center has been established at USC with support over the last year from multiple awards from the NCRR and other NIH Institutes. Support from these agencies has been used to purchase several miniaturized versions of x-ray, optical, ultrasound and radio nuclear scanners for studies in small laboratory animals, as well as hot cells for radio synthesis of imaging agents for pre-clinical and clinical PET studies, and a human use 3T MRI. A central component of the molecular imaging effort has been the availability of a medical cyclotron for production of positron-emitting isotopes. Unfortunately, because of its age (nearly 20 years), the existing cyclotron can no longer service the needs of our ever-expanding network of investigators at USC and in the surrounding community. This proposal requests funding for a replacement cyclotron on the USC Health Sciences Campus. The requested device will be housed and operated in the Radiochemistry Facility of the Molecular Imaging Center, where it will complement other shared-use devices. The instrument chosen has numerous features conducive to efficient operation, including, ability to reliably produce PET radioisotopes in sufficient quantity and specific activity for use in basic radiochemistry research as well as for pre-clinical and investigative clinical imaging studies with current and future radiopharmaceuticals; is operator friendly; maximizes radiation safety of operators; is environmentally friendly with minimal radioactivity release and efficient use of utilities; has a robust, programmable and upgradable operating system with off-site monitoring and diagnostics capability; has minimal downtime; and comes with a strong service and parts support system. In addition, manufacturing of the primary systems components, assembly of device and service contract work are all provided for within the US, maximizing the impact of the purchase on US job creation and security. Investigators representing multiple disciplines including medicine, chemistry, pharmacology, and engineering, will use the requested cyclotron. Addition of the requested instrument will increase the productivity of assembled PHS-funded investigators from USC, Caltech and City of Hope who are working in these areas. The discoveries and advancements made by these investigators will ultimately have a direct positive impact on the local community as well as public health in general.
PUBLIC HEALTH RELEVANCE: The Cyclotron and Radiochemistry Laboratory, along with the complementary molecular imaging resources available at USC, are indispensable to the growth of a broad spectrum of research programs at USC. Replacement of the aging cyclotron will strengthen both ongoing work in oncology, neurosciences, chemistry, pharmacy and genetic medicine by researchers, as well as greatly enhancing the ability of this Core to support new research. This enhancement will allow our investigators to continue to conduct cutting-edge research that will be reflected in our future grant submissions and publications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase Contrast Tomographic X-Ray Microscope System
-
批准号:8734930
-
项目类别:
-
资助金额:$111.13万
-
财政年份:2015
-
负责人:Peter Stephen Conti
-
依托单位:
Small Animal Photoacoustic Imaging Unit: Integrating Optical Imaging with High Fr
-
批准号:8640794
-
项目类别:
-
资助金额:$59.9万
-
财政年份:2014
-
负责人:Peter Stephen Conti
-
依托单位:
The Tetrazine Ligation for Efficient 18F Labeling and Pretargeted Imaging/Radiotherapy of Cancer
-
批准号:8900694
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2013
-
负责人:Peter Stephen Conti
-
依托单位:
EphB4 as Novel Target for Breast Cancer Imaging
-
批准号:8114963
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2011
-
负责人:Peter Stephen Conti
-
依托单位:
EphB4 as Novel Target for Breast Cancer Imaging
-
批准号:8245791
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2011
-
负责人:Peter Stephen Conti
-
依托单位:
Ultra-High Resolution CT Specimen Scanner for In Vitro Applications
-
批准号:7795629
-
项目类别:
-
资助金额:$49.16万
-
财政年份:2010
-
负责人:Peter Stephen Conti
-
依托单位:
Digital X-Ray Device for Molecular Imaging Center
-
批准号:7795619
-
项目类别:
-
资助金额:$13.48万
-
财政年份:2010
-
负责人:Peter Stephen Conti
-
依托单位:
High Resolution Ultrasound Resource for Molecular Imaging Center
-
批准号:7215090
-
项目类别:
-
资助金额:$36.2万
-
财政年份:2007
-
负责人:Peter Stephen Conti
-
依托单位:
IMAGING SYSTEM: MAGNESIUM DEFICIENCY: BONE & MINERAL METABOLISM IN RAT
-
批准号:6973482
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2004
-
负责人:Peter Stephen Conti
-
依托单位:
Micro Computerized Tomography Imaging System
-
批准号:6731469
-
项目类别:
-
资助金额:$37.83万
-
财政年份:2004
-
负责人:Peter Stephen Conti
-
依托单位:
IMAGING SYSTEM: BONE & OSTEOPOROSIS, MOUSE MODEL
-
批准号:6973481
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2004
-
负责人:Peter Stephen Conti
-
依托单位:
IMAGING SYSTEM: CANCERS: PROSTATE, COLON
-
批准号:6973480
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2004
-
负责人:Peter Stephen Conti
-
依托单位:
Development of a Cellular and Molecular-Based Cancer Im*
-
批准号:6514556
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2001
-
负责人:Peter Stephen Conti
-
依托单位:
Development of a Cellular and Molecular-Based Cancer Im*
-
批准号:6344464
-
项目类别:
-
资助金额:$39.2万
-
财政年份:2001
-
负责人:Peter Stephen Conti
-
依托单位:
SMALL ANIMAL PET SCANNER FOR CANCER APPLICATIONS
-
批准号:6288088
-
项目类别:
-
资助金额:$49.55万
-
财政年份:2001
-
负责人:Peter Stephen Conti
-
依托单位:
Development of a Cellular and Molecular-Based Cancer Im*
-
批准号:6658927
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2001
-
负责人:Peter Stephen Conti
-
依托单位:
DUAL HOT CELL SYSTEM AND AUXILLARY EQUIPMENT
-
批准号:2503076
-
项目类别:
-
资助金额:$34.31万
-
财政年份:1998
-
负责人:Peter Stephen Conti
-
依托单位:
IN VIVO MARKER OF CELL PROLIFERATION FOR PET STUDIES
-
批准号:2871923
-
项目类别:
-
资助金额:$55.53万
-
财政年份:1997
-
负责人:Peter Stephen Conti
-
依托单位:
IN VIVO MARKER OF CELL PROLIFERATION FOR PET STUDIES
-
批准号:2654249
-
项目类别:
-
资助金额:$51.62万
-
财政年份:1997
-
负责人:Peter Stephen Conti
-
依托单位:
IN VIVO MARKER OF CELL PROLIFERATION FOR PET STUDIES
-
批准号:2010953
-
项目类别:
-
资助金额:$52.03万
-
财政年份:1997
-
负责人:Peter Stephen Conti
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: